Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Business & Regulation Business Practice

What Trump’s Latest Moves Mean for the Industry

| 6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

Discovery & Development Analytical Science

Understanding Mass Spectrometry for Biologics

| Chris Nortcliffe | 9 min read

As biologics become more complex, mass spec becomes more indispensable than ever in the drug developer’s toolbox.

Manufacture Bioprocessing - Upstream & Downstream

Building Better Biologics – While Being Sustainable

| Hayley Crowe | 7 min read

Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference

Business & Regulation Business Practice

The Challenges and Successes of A Biotech Startup

| Dan Williams | 3 min read

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

Manufacture Bioprocessing - Upstream & Downstream

Appreciating the Art of Lyophilization

| Walter Pebley | 6 min read

Biopharma has been using lyophilization to stabilize injectables for more than 80 years, but the technique is capable of so much more.

Business & Regulation Bioprocessing - Upstream & Downstream

The Power List Personified: Getting to Know Beatrice Lavery

| Rob Coker | 4 min read

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Discovery & Development Analytical Science

Cracking the Code of Phages and How They Can Fight TB

| Rob Coker | 2 min read

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB.

Business & Regulation Advanced Medicine

This Week’s Biopharma News: Long-Running CRISPR Patent Case Reopened

| Rob Coker | 4 min read

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity

Manufacture Contract Development Services

Streamlining Biologics from IND to Commercial Scale with Continuous Manufacturing

| Nick Hutchinson | 4 min read

When it comes to continuous cGMP biomanufacturing, Just – Evotec Biologics’ J.DESIGN platform integrates data analytics and continuous manufacturing

Business & Regulation Standards & Regulation

The Trump Effect on Biopharma: FDA Disruption, Tariffs, and Funding Cuts

| 5 min read

Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker